Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
about
Vaccine adjuvants: mode of actionBiological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.Defined synthetic vaccines.Enhancement of vaccine potency through improved delivery.New age adjuvants and delivery systems for subunit vaccines.A Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.Surface engineering of liposomes for stealth behavior.Periodontal vaccine: A dream or reality.Enhanced cell killing and apoptosis of oral squamous cell carcinoma cells with ultrasound in combination with cetuximab coated albumin microbubbles.Liposomal adjuvants for human vaccines.What's going on in vaccine technology?Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.Preliminary evaluation of the immunoenhancement potential of Newcastle disease vaccine formulated as a cationic liposome.Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses
P2860
Q21131210-70EEE105-2499-48CF-B888-1F263F22E0F1Q34097835-15F6DF6E-4B12-4CFE-8AB7-CCDEA89EB3B2Q34280941-2F76A869-A2C7-4AEB-BA82-40157C4811ECQ35842648-79D48E32-26A9-489E-9289-B2D135DE7A36Q36265526-95F5408A-8DCA-4717-BFE8-32E3565AEAA2Q36604334-4A7D767F-8896-4C77-BDCD-B3883BD3C32EQ36792020-09E25948-7AD5-4803-A3A0-1AC1F21D2BC2Q36850638-31A58A92-7DEE-40B6-9AB3-24F7C0123B1AQ37415968-EC823326-9ADB-40F9-89D1-35F7D3AC9370Q38596703-6AEB21DE-C75B-41DE-9A51-2C3523A01C11Q38694992-1A716525-8511-4350-993C-233AFA89678DQ38729260-BF63F031-B2B8-4BE0-844E-438B9D07BB04Q41452212-05088F0A-A355-4DB3-B94F-98DA48715A70Q46441246-F6698B08-E792-4AD6-AFBB-C1AC34FD5C56Q50588771-D17CE3C3-0840-4458-AD67-5CD2B38D77F1Q58751640-ED1EB6F7-9D4A-43F1-9138-F50990A7DE29
P2860
Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@ast
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@en
Adjuvant properties of non-phospholipid liposomes
@nl
type
label
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@ast
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@en
Adjuvant properties of non-phospholipid liposomes
@nl
prefLabel
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@ast
Adjuvant properties of non-pho ...... ls for human vaccine antigens.
@en
Adjuvant properties of non-phospholipid liposomes
@nl
P2093
P1433
P1476
Adjuvant properties of non-pho ...... als for human vaccine antigens
@en
P2093
C L Varanelli
D F Wallach
P304
P356
10.1016/0264-410X(95)00182-Z
P407
P50
P577
1996-02-01T00:00:00Z